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Abstract
Objective: Respiratory abnormalities such as upper airway obstruction are
common in Parkinson’s disease (PD) and are an important cause of mortality
and morbidity. We tested the effect of pedunculopontine region (PPNr) stimu-
lation on respiratory maneuvers in human participants with PD, and separately
recorded PPNr neural activity reflected in the local field potential (LFP) during
these maneuvers. Methods: Nine patients with deep brain stimulation electrodes
in PPNr, and seven in globus pallidus interna (GPi) were studied during trials
of maximal inspiration followed by forced expiration with stimulation OFF and
ON. Local field potentials (LFPs) were recorded in the unstimulated condition.
Results: PEFR increased from 6.41  0.63 L/sec in the OFF stimulation state to
7.5 L  0.65 L/sec in the ON stimulation state (z = 2.666, df = 8,
P = 0.024). Percentage improvement in PEFR was strongly correlated with
proximity of the stimulated electrode contact to the mesencephalic locomotor
region in the rostral PPN (r = 0.814, n = 9, P = 0.008). Mean PPNr LFP power
increased within the alpha band (7–11 Hz) during forced respiratory maneuvers
(1.63  0.16 lV2/Hz) compared to resting breathing (0.77  0.16 lV2/Hz;
z = 2.197, df = 6, P = 0.028). No changes in alpha activity or spirometric
indices were seen with GPi recording or stimulation. Percentage improvement
in PEFR was strongly positively correlated with increase in alpha power
(r = 0.653, n = 14 (7 PPNr patients recorded bilaterally), P = 0.0096). Inter-
pretation: PPNr stimulation in PD improves indices of upper airway function.
Increased alpha-band activity is seen within the PPNr during forced respiratory
maneuvers. Our findings suggest a link between the PPNr and respiratory perfor-
mance in PD.
Introduction
Respiratory abnormalities are common in Parkinson’s Dis-
ease (PD) and are a major cause of death.1 Such abnormali-
ties include abnormal respiratory patterns, aspiration
pneumonia and chronic airflow limitation.2,3 The latter is
believed to be caused by upper airway obstruction (UAO)
due to weakness, hypokinesia or aberrant contraction of
the striated musculature around the upper airway2,4 and
has been suggested to be an important factor in secretion
retention, atelectasis, and aspiration pneumonia.1,2,5
Irregular and jerky movements of both the glottis and
supraglottic structures with sudden and intermittent clo-
sure of the airway are seen on fiberoptic endoscopic
examination of the upper airways in extrapyramidal dis-
orders including PD. In addition, there is often a fixed
reduction in laryngeal diameter believed to be due to
tonic activation of vocal fold adductors.2 These abnormal-
ities have been reflected in respiratory function tests signi-
fying UAO, manifesting as diminished peak expiratory
flow rate (PEFR) and maximal flow at 50% of forced vital
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capacity (FEF50), with an increased ratio of forced expira-
tory volume in one-second (FEV1) to PEFR.2,4,6
The nonmotor benefits of deep brain stimulation
(DBS) have attracted recent interest.7,8 We have previ-
ously shown that stimulation of selected subcortical areas
can improve PEFR by up to 30% in humans treated for
movement and chronic pain disorders, an effect which is
presumed to be mediated by changes in autonomic out-
flow to airway smooth muscle rather than changes in
inspiratory/expiratory muscle tone.9 The sites stimulated
in this previous study were the periaqueductal grey matter
of the midbrain, implicated in integrated behavioral
responses10,11 and in the central autonomic network,12
and the subthalamic nucleus. Other sites used as controls
in that study were the globus pallidus interna (GPi) and
the sensory thalamus. Although stimulation of the GPi
and sensory thalamus are therapeutic in movement and
chronic pain disorders, respectively, they are not impli-
cated in the brain’s cardiorespiratory neurocircuitry and
indeed they conferred no change in lung function.
The mesencephalic locomotor region (MLR), which
includes the rostral PPN,13–15 has been shown to modu-
late autonomic variables in decerebrate or anesthetized
animals.16,17 In particular, animal studies show gluta-
matergic neurones from the MLR project directly to the
medullary respiratory generator and play a key role in
changes in respiration linked to motion.18 PPN region
(PPNr) stimulation is a novel therapy for freezing of gait
and postural instability in PD19–22 and is suggested to
improve control of axial musculature.21 Accordingly, we
hypothesize that PPNr may improve UAO in patients
with PD. In addition, we define whether changes in local
patterns of oscillatory synchrony implicated in axial
motor control may also be evident in voluntary respira-
tion. PPNr oscillations tend to synchronize within the 7–
11 Hz band,23 and this activity increases during, and cor-
relates with, gait performance.24 Hence our second
hypothesis is that voluntary respiration will be accompa-
nied by increases in alpha activity in the PPNr.
Methods
Patients
Nine patients with PD (meeting UK Brain Bank Criteria)
manifesting with freezing of gait or postural instability,
receiving chronic bilateral PPN region (PPNr) stimulation
were recruited from centers in Oxford, UK, and Brisbane,
Australia. Ethical approval was obtained from both cen-
ters in addition to written informed consent. Indications
for this treatment and implantation technique have been
reviewed elsewhere.19 PPNr stimulation was of a mean
amplitude 2.8 volts (V) (range 2.2–4.3 V), mean frequency
32 Hz (range 20–40 Hz) and a 60 microsecond pulse
width. Patient and stimulation characteristics are summa-
rized in Table 1. Seven cases with implanted GPi elec-
trodes for dystonia in Oxford, UK, were used as the
control group. Mean GPi age was 51 years (range 22–
66 years), two males, five females, mean amplitude 2.4
volts (range 2–3 volts), mean frequency 114 Hz (range
60–130 Hz) and a 90 microsecond pulse width.
Respiratory maneuvers
Testing was undertaken by a single clinician trained in
the supervision of spirometry by the lung function labo-
ratory within the Department of Respiratory Medicine,
Churchill Hospital, UK, and at the center in Brisbane,
and patients were asked to attend for testing having taken
their normal PD medications. Patients were trained to
perform spirometry according to the European Respira-
tory Society guidelines.25 All patients were able to per-
form spirometry competently. Patients were tested whilst
sitting comfortably upright in a chair with the neck in a
neutral position. No nose clip was applied. A thoracic gir-
dle was applied to continuously transduce changes in tho-
racic circumference related to breathing. After a period of
resting breathing, a forced respiratory maneuver, consist-
ing of a maximal inspiration followed by a forced expira-
tion was performed. A clinical Spirolab 2 spirometer
(Medical International Research USA, Inc) recorded lung
function indices. Patients performed three trials of maxi-
mal inspiration followed by forced expiration each for the
conditions of stimulation OFF and ON. Stimulation
parameters were the same as at the patient’s regular ther-
apeutic settings. The ON/OFF order was randomized and
patients were blinded to whether stimulation was ON or
OFF, however, the experimenter was not blinded to
patient condition. There was a 10-minute wash-out per-
iod between DBS ON and DBS OFF conditions based on
previous findings that cardiorespiratory parameter
Table 1. Demographic and stimulation parameters in patients receiv-
ing pedunculopontine nucleus region stimulation.
Age
(yrs)/Sex
Stimulation parameters
(Voltage, Pulse width, Frequency)
47/M 2.2v, 60 lsec, 35 Hz
77/M Left 2.5v, Right 2.8v, 60 lsec, 35 Hz
62/F 4v, 60 lsec, 35 Hz
73/M 4.3v, 60 lsec, 35 Hz
73/F 3v, 60 lsec, 35 Hz
57/M 2.2v, 60 lsec, 20 Hz
56/M 2.5v, 60 lsec, 20 Hz
68/M 3.0v, 60 lsec, 40 Hz
54/M 2v, 60 lsec, 30 Hz
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changes occur within seconds to minutes of deep brain
stimulation adjustments.9,26,27
Electrophysiological recordings
In patients with externalized electrodes, it was possible to
simultaneously record local field potentials (LFPs) during
resting breathing and forced respiratory maneuvers in the
OFF stimulation state. As a control, LFPs were recorded
during the same conditions from patients with GPi elec-
trodes, as this nucleus has previously not produced
changes in lung function when stimulated.9 Recordings
were made from adjacent contacts of each deep brain
macroelectrode (Medtronic, model 3389) in a bipolar
configuration. Signals were filtered at 0.5–500 Hz and
amplified (10,000x) using isolated CED 1902 amplifiers
and digitized using CED 1401 Mark II at a rate of
2.5 kHz (Cambridge Electronic Design, Cambridge, UK).
LFPs were displayed online and saved onto hard disk
using Spike II (CED) and subsequently analyzed offline.
Fast Fourier Transformations were applied to decompose
the LFP signal into its constituent frequencies, specifically
the 7–11 Hz band, although the full power spectrum was
reviewed for the presence of artifact prior to filtering.
Mean power within the 7–11 Hz band during forced res-
piratory maneuvers across all trials was compared to
mean 7–11 Hz band power during randomly selected
periods of resting breathing.
Upper airway & other spirometry
measurements
We recorded PEFR, defined as the highest flow achieved
from a maximum forced expiration started without hesi-
tation from a position of maximal lung inflation,28 maxi-
mal flow at 50% of forced vital capacity (FEF50), forced
expiratory volume in one-second (FEV1) defined as the
maximal volume of air exhaled in the first second of a
forced expiration from a position of full inspiration,25
and forced vital capacity (FVC), defined as the maximal
volume of air exhaled with maximally forced effort from
a maximal inspiration.25 FEV1/PEFR and FEV1/FVC
ratios were derived. Primary outcome variables were those
indicating upper airway flow, namely PEFR, FEF50, and
FEV1/PEFR ratio2,4,6.
Electrode contact mapping
Preoperative MRI was fused to post-operative head com-
puterized tomograms (CT) using image fusion software
(Radionics Inc., Burlington, MA, USA). Postoperative CT
images were acquired on the day of surgery. Rostro-caudal
distances of the active electrode contacts from the
pontomesencephalic (PM) line were recorded whereby
increasing positivity depicted an increasingly rostral loca-
tion. To illustrate the locations of the PPN electrodes,
anatomical landmarks were used to transform the electrode
positions onto the Montreal Neurological Institute (MNI)
standard and structural brain template of 152 averaged
brains using the FMRIB Software Library (FSL).29,30
Statistical analysis
Data were analyzed using the Statistical Package for Social
Sciences (SPSS version 11, SPSS Inc., Chicago, IL). The
Kolmogorov–Smirnov Test demonstrated that PEFR per-
centage improvement, FVC, and mean electrode contact
depth data were normally distributed. To compare the
difference between condition means, paired samples
t-tests were applied to FVC data, whereas the Wilcoxon
signed-rank test was applied to the non-Gaussian dis-
tributed variables. All tests were two tailed. P < 0.05 after
correction for multiple comparisons were considered sig-
nificant.31 Percentage PEFR improvement with stimula-
tion was correlated with the mean of the active contact
depths of the two electrodes in each patient using Pear-
son’s correlation coefficient. Means and standard error of
the means are given in the text.
Results
Indices of upper airway function
PEFR improved in patients receiving PPNr stimulation,
and the increase was significant from 6.41  0.63 L/sec in
the OFF stimulation state to 7.5  0.65 L/sec in the ON
stimulation state (z = 2.666, df = 8, P = 0.024; Fig. 1).
Within the control group, PEFR was not changed by GPi
stimulation. Mean PEFR was 8.31  1.11 L/sec in the OFF
stimulation state compared to 8.33  1.06 L/sec in the ON
stimulation state (z = 0.340, df = 6, P = 0.734).
In the PPNr group, FEF50 was lower than predicted in
the OFF DBS state with a mean predicted percentage of
90% compared to 100% ON DBS. Mean FEF50 increased
from 3.45  0.36 L/sec to 3.83  0.5 L/sec with PPN
stimulation, although this did not reach significance
(P = 0.063). Mean FEV1 change was only marginal,
increasing with PPNr stimulation, and this was not signif-
icant (2.68  0.18 L Off vs. 3.00  0.31 L On DBS,
P = 0.139; See Table 2).
The ratio of FEV1/PEFR improved with PPNr stimula-
tion in all patients. The criteria for UAO (FEV1/PEFR
ratio > 8.5 mL/L per min3) were satisfied in one patient
with a mean FEV1/PEFR ratio of 8.83 mL/L per min
without stimulation. Mean FEV1/PEFR ratio was reduced
to 8.19 mL/L per min with stimulation and therefore no
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Figure 1. Percentage changes in (A) Mean alpha band synchronization during forced respiratory maneuvers compared to resting breathing in the
PPN region (red) versus the GPi (blue); and (B) Mean peak expiratory flow rate across all patients with stimulation of the PPN region (red) versus
the GPi (blue). Error bars represent standard errors.
4 ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
PPN Stimulation Improves UAO in PD J. A. Hyam et al.
longer within the UAO critical range. The same patient’s
mean PEFR improved from 5.7 to 7.4L/sec with stimula-
tion (29.9% improvement). Across all patients, mean
FEV1/PEFR ratio improved with stimulation from
7.21  0.45 mL/L per min to 6.75  0.42 mL/L per min
(z = 2.666, df = 8, P = 0.016). Given that the FEV1
change was only marginal, the change in FEV1/PEFR ratio
with stimulation appears to reflect increases in PEFR
only, suggesting an upper rather than lower airway func-
tion improvement.
General indices of lung function
There was an increase in mean FVC from 3.22  0.21L
to 3.50  0.30L, which was not significant (t = 1.298,
df = 8, P = 0.231). No patients showed an FEV1/FVC
ratio of less than 70% with stimulation ON or OFF stim-
ulation, which would have suggested overall airway
obstruction.32 FEV1/FVC ratio showed no significant
change between conditions (OFF 83.5  2.8% vs. ON
stimulation 85.3  3.4%; z = 1.540, df = 8, P = 0.123).
Stimulation depth versus upper airway
function
Active PPNr electrode contact depth amongst patients
was distributed along the rostro-caudal length of the
PPNr (see Fig. 2). Percentage improvement in PEFR was
strongly correlated with the rostral location of active con-
tacts (see Fig. 3). Mean active contact depth from the PM
line explained 66% of the variance of percentage PEFR
improvement with stimulation (r = 0.814, n = 9 and
P = 0.008). Thus, the more rostral the stimulation, the
greater the percentage PEFR improvement.
Electrophysiology: alpha band activity
PPNr LFPs were recorded in seven cases and GPi LFPs were
recorded in seven cases. Mean PPNr LFP power was
significantly higher within the alpha band during forced
respiratory maneuvers (1.63  0.16 lV2/Hz) compared to
resting breathing (0.77  0.16 lV2/Hz; z = 2.197,
df = 6, P = 0.028) (see Fig. 4). Alpha band power
increased during maximal inspiration and peaked during
forced expiration, before returning to baseline levels (see
Fig. 5).
In contrast, no change in mean alpha power within the
control GPi nuclei was seen during forced respiratory
maneuvers (1.25  1.49 lV2/Hz) compared to resting
breathing trials (1.38  1.60 lV2/Hz; z = 1.693, df = 6,
P = 0.090) (see Fig. 4).
Across all PPNr and GPi patients studied, percentage
increase in PEFR on stimulation was strongly positively
correlated with percentage increase in alpha power during
spirometry (Spearman’s r = 0.653, n = 14, P = 0.0096).
Discussion
The main finding of this study is that low-frequency elec-
trical stimulation of the PPNr produced a significant
increase in spirometric indices of upper airway function,
whereas recordings from the same stimulation target
revealed an increase in alpha activity during the spiromet-
ric maneuvers of maximal inspiration and forced expira-
tion compared to resting breathing in PD patients. No
such changes were seen when stimulating and recording
from the GPi.
Upper airway dysfunction in PD is an important cause
of morbidity and can lead to death. UAO manifests as a
reduced PEFR and FEF50, and an increased FEV1/PEFR
ratio.2,4,6 In our study, improvements were seen in all
three of these indices with two of the three reaching sta-
tistical significance. PEFR captures the initial 15 millisec-
onds of forced expiration. This likely reflects upper
airway flow as firstly, this early expiratory period receives
a major contribution from the large proximal airways,
and secondly because it is predominantly limited by tur-
bulence of flow in the large upper airways.2 In contrast,
FEV1 captures a longer time window and reflects lower
airway performance as well. There was no significant
change in FEV1 in our study and the changes in FEV1/
PEFR ratio were due to increases in PEFR. Therefore,
PPNr stimulation predominantly improved upper, rather
than lower, airway performance. This may be a property
of PPNr connectivity influencing only one end of the res-
piratory tree or alternatively may reflect the fact that it is
the upper airways which are affected by PD and there is
thus more scope to produce a detectable change in their
performance. Although changes in clinical outcomes were
not formally recorded in this patient group, we would
anticipate that clinical consequences of improved upper
airway performance would include improvements in
Table 2. Change in indices of upper airway function ON versus OFF
PPN region stimulation.
Stimulation
PEFR
Mean  SE
(L/sec)
FEV1/PEFR
Mean  SE
(mL/L per min)
FEF50
Mean  SE
(L/sec)
ON 7.45
( 0.65)
6.75
( 0.42)
3.83
( 0.54)
OFF 6.41
(0.63)
7.21
( 0.45)
3.45
( 0.36)
z, df 2.666, 8 2.666, 8 1.863, 6
P 0.024* 0.016* 0.063
SE, Standard error. * indicates significant (p < 0.05)
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symptoms of dyspnea and reduction in problems such as
sleep disordered breathing, which has been associated
with worse functional outcomes following stroke.33
However, further clinical studies are required to demon-
strate this. There was a strong correlation between per-
centage PEFR improvement and a more rostral location
Figure 2. Location of active pedunculopontine region electrode contacts in Montreal Neurological Institute standard space. (A) Sagittal section;
(B) Equivalent rat sagittal section demonstrating the mesencephalic locomotor region (MLR) above the pontomesencephalic (PM) line (adapted
from Chong & Bedford); (C) Coronal section.
6 ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
PPN Stimulation Improves UAO in PD J. A. Hyam et al.
of stimulation within the PPNr. The rostral PPN is within
the MLR. Chong & Bedford described arterial blood pres-
sure and heart rate increases in addition to locomotion in
rats after electrical stimulation of the MLR,17 and a subset
of neurons within the MLR have also been identified as
being responsible for increasing ventilation with locomo-
tion.34 In the present study, stimulation was in the rostral
PPN above the PM line, at the level of the inferior col-
liculus and rostral to the parabrachial nucleus. Stimula-
tion was lateral and separate from the periaqueductal gray
area. The two patients (yellow and cyan active contacts in
Fig. 2) who experienced the greatest PEFR improvement
in our study received stimulation to the equivalent area
in the human.
The link between the PPNr and respiratory function was
strengthened by our finding of an increase in local alpha
activity upon maximal inspiration and forced expiration.
This change was not observed in GPi, making it unlikely to
be a cardiovascular or mechanical epiphenomenon of the
respiratory maneuver. Could this activity reflect the activa-
tion of the PPNr outflow that innervates the respiratory
musculature, given that driving this area at lower frequen-
cies than used at other motor targets for DBS improves
spirometric function? It may be that DBS modulates the
activity of PPNr cholinergic neurons, which normally have
an inhibitory effect on muscle tone,35, and thus improves
function of respiratory muscles, which have diminished
function in PD.36 PPNr alpha power has also been shown
to increase in PD patients during walking,24 which is again
improved by low-frequency PPNr stimulation, and thus the
signal may be related to changes in activity in the MLR as
discussed above.
An alternative hypothesis is that alpha band synchro-
nization may reflect attentional changes associated with
Figure 3. Scatterplot demonstrating the correlation between mean active contact depth from the pontomesencephalic line versus improvement
in peak expiratory flow rate.
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the spirometric maneuver. Indeed, the PPN forms part of
the ascending arousal system, a region implicated in alert-
ness. It is postulated that alpha activity may be an index
of active suppression to block out distracters to facilitate
focusing on a desired subject.37,38 The improved upper
airway function in this study might then thus been the
result of an improved focus of internal attention during
the task, as has been argued for voluntary limb move-
ments.23
It is also possible that current spread to other brain
regions such as the Kolliker-Fuse nucleus and the lateral
parabrachial nucleus may have been responsible for the
respiratory effects of stimulation, rather than direct
stimulation of the PPN proper. The parabrachial/Kolliker-
Fuse complex in the dorsal brainstem is known to have
various modulatory effects on respiratory responses
depending on the precise site of stimulation, including
promotion of hyperpnea, inspiratory response, and apnea,
(e.g., Chamberlin and Saper, 199439) and also to be
important for locomotor-respiratory entrainment,40 which
may be significant in the context of neuromodulation that
is known to improve gait.
There are a number of potential study limitations that
should be borne in mind. First, we acknowledge that elec-
trode positions were based on post-op CT scans carried
out on the day of surgery. Repeat CT scans were not
Figure 4. Local field potential power spectra showing increased alpha band (7-11 Hz) synchronisation during forced respiratory manoeuvres (red)
compared to resting breathing (blue) across all trials in two representative patients with 95% confidence limits as thin lines. Upper:
Pedunculopontine Nucleus (PPN) region in one patient; Lower: Globus Pallidus interna (GPi) in one patient.
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acquired at the time of testing, and there was therefore a
theoretical potential for small degrees of electrode migra-
tion between the post-op CT and the time of testing. All
patients had PD and therefore the electrophysiological
activity seen in the PPNr may be a feature specific to the
PD phenotype and thus it may not be possible to general-
ize these results to non-PD subjects. The GPi patients suf-
fered from dystonia rather than PD. The lack of
electrophysiological change is consistent with studies that
have shown no change in oscillatory activity during antic-
ipation or performance of exercise despite increases in
heart rate, mean arterial blood pressure, and respiratory
rate.41 Second, the lack of spirometric improvement with
GPi stimulation, is consistent with previous evidence
showing no lung function change9 nor change in cardio-
vascular performance37 after GPi stimulation. None of the
patients studied had known respiratory deficits and so the
improvements we detected may have been near ceiling
level; future studies are necessary to evaluate whether
upper airway function can be improved still further in
symptomatic patients, and whether the improvements
seen in the present patients translate to longer term
improvements in respiratory outcomes such as dimin-
ished risk of aspiration.
Conclusion
This is the first interventional study in humans to
demonstrate an improvement in lung function by elec-
trical stimulation of the PPN region. Improvement was
in upper airway function in PD patients. The sites
stimulated also synchronized their activity in the 7–
11 Hz alpha band during forced spirometric maneuvers.
The mesencephalic locomotor region has previously
been shown to modulate cardiovascular performance in
animals and in this study low-frequency stimulation
was associated with a greater lung function improve-
ment when delivered to rostral part of the PPN region.
Thus this study suggests a functional and electrophysio-
logical link between the PPN region, particularly its
Figure 5. Simultaneously recorded physiological signals in a representative patient. (A) Respiratory trace showing increase in thoracic
circumference during maximal inspiration followed by a rapid decrease in circumference during forced expiration; (B) Raw LFP during exertional
respiratory maneuver; (C) Time frequency spectrogram demonstrating an increase in alpha 7–11 Hz power during maximal inspiration and forced
expiration.
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rostral portion, and upper airway performance. It
remains to be seen if this is true outside of PD, and
whether the scale of the effect could, under circum-
stances of impaired lung function, afford symptomatic
improvement.
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